$8.00
0.091.14%
Comments
Loading...
Avadel Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AVDL | Benzinga
Avadel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$58.71M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$138.16M
Analyze the earnings history of Avadel Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Avadel Pharmaceuticals (AVDL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.05 | $-0.04 | -25.0 % |
| Q3 | 2024-11-12 | $-0.03 | $-0.05 | 40.0 % |
| Q2 | 2024-08-08 | $-0.14 | $-0.16 | 12.5 % |
| Q1 | 2024-05-08 | $-0.30 | $-0.21 | -42.9 % |
Avadel Pharmaceuticals (AVDL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $50.41M | $50.03M | 0.76 % |
| Q3 | 2024-11-12 | $50.03M | $48.61M | 2.91 % |
| Q2 | 2024-08-08 | $41.50M | $37.58M | 10.4 % |
| Q1 | 2024-05-08 | $27.18M | $26.67M | 1.90 % |
FAQ
When is Avadel Pharmaceuticals (NASDAQ:AVDL) reporting earnings?
Avadel Pharmaceuticals (AVDL) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Avadel Pharmaceuticals (NASDAQ:AVDL)?
The Actual EPS was $-0.05, which missed the estimate of $-0.04.
What were Avadel Pharmaceuticals’s (NASDAQ:AVDL) revenues?
The Actual Revenue was $50.4M, which beat the estimate of $50M.
Browse earnings estimates, EPS, and revenue on all stocks.